PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2000 | 3 | 118-140
Article title

Biotechnology of drugs on the verge of 21st century

Authors
Title variants
Languages of publication
PL
Abstracts
EN
At present most classical pharmaceutical technologies reach high level of industrial perfection. The best example of those achievements is the biotechnology of penicillins. Biosynthetic penicillin production using highly productive strains of Penicillium chrysogenum is followed by an enzymatic hydrolysis of the product using microbial penicillin acylase, the best sources of which are recombinant strains of Escherichia coli. The resulting aminopenicillanic acid is the starting material for chemical synthesis of a large number of semisynthetic penicillins. Research and development of the biotechnology of antibiotics created solid fundamentals for other biotechnological processes in the pharmaceutical industry, i.e. production of amino acids, organic acids, enzymes and enzyme inhibitors, vitamins, alkaloids, dextran, steroid drugs and others. In addition to the continuous improvement of the classical technology completely new bioprocesses were introduced to the pharmaceutical industry in the recent years as a result of unprecedented progress in genetic engineering, hybridoma techniques and cell cultures in vitro. The new group of polypeptide/protein biopharmaceuticals includes peptide hormones (e.g. insulin, growth hormones, gonadotropins), growth factors (e.g. insulin-like growth factors, epidermal growth factors), haematopoietic growth factors (e.g. erythropoietin, colony stimulating factors), blood proteins (e.g. clotting factors VIII, IX, XII and XIII, tissue plasminogen activator, streptokinase), cytokines (e.g. interferons, interleukines and tumor necrosis factor) and monoclonal antibodies. Another new area of genetic engineering and biotechnology is the production of nucleic acid drugs, which are proposed for both gene and antisense therapy.
Publisher

Journal
Year
Issue
3
Pages
118-140
Physical description
Contributors
author
References
Document Type
article
Publication order reference
A. Chmiel, Samodzielna pracownia Biosyntezy Srodkow Leczniczych, Akademia Medyczna, ul. Muszynskiego 1, 90-151 Lodz, Poland
Identifiers
YADDA identifier
bwmeta1.element.element-from-psjc-f6f19bbc-1ae6-30b6-a1e7-0a36058bc00c
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.